Neuroblastoma in children less than 1 year of age;Neuroblastoma en ninos menores de 1 ano

Anales Espanoles de Pediatria

Volumn 47, Issue 6, 1997, Pages 584-590

  Castel Sanchez V ^a   Melero Moreno, C ^b   Garcia Miguel Garcfa Rosados, P ^c   Navajas Gutierrez, A ^a   Ruiz Jimenez J I ^b   Navarro Fos, S ^a   Garin Valle, J C ^a   Galbe Sada, M ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c HOSPITAL INFANTIL LA FE   (Spain)

Author keywords

Children less than 1 year old; Infants; Neuroblastoma; Prenatal diagnosis; Prognostic factors; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHOLAMINE; CISPLATIN; CYCLOPHOSPHAMIDE; DNA; DOXORUBICIN; FERRITIN; GLYCOPROTEIN P; LACTATE DEHYDROGENASE; TENIPOSIDE;

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DNA DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROBLASTOMA; NEWBORN; ONCOGENE C MYB; PROGNOSIS; TREATMENT OUTCOME; AGE DISTRIBUTION; BONE TUMOR; BRAIN TUMOR; FEMALE; LIVER TUMOR; MALE; METASTASIS; MORTALITY; PROSPECTIVE STUDY; SURVIVAL RATE;

AGE DISTRIBUTION; BONE NEOPLASMS; BRAIN NEOPLASMS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; NEUROBLASTOMA; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031297731     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Wilson MK, Draper GJ. Neuroblastoma, its natural history and prognosis: a study of 487 cases. BrMedJ 1974; 3:301- 307.
2. Jereb B, Bretsky SS, Vogel R, Helson L. Age and prognosis in neuroblastoma. Review of 112 patients younger than 2 years. Am J Pediatr Hemaiol Oncol 1984; 6:233-243.
3. Evans AE, Baum E, Chard R. Do infants with stage IV-S neuroblastoma need treatment? Arch Dis Child 1981; 56:271- 4.
4. Nickerson HJ, Nesbit ME, Grosfeld JL, Baehner RL, Sather H, Hammond D. Comparison of stage IV and IV-S in neuroblastoma in the first year of life. Med Pediatr Oncol 1995; 13:261-268.
5. Bowman LC, Hancock ML, Santana VM, Hayes FA, Kun L, Parham DM, Furman DM, Rao BN, Green AA, Crist \VM. Impact of Intensified Therapy on Clinical Outcome in Infants and Children with Neuroblastoma: The St Jude Children's Research Hospital Experience, 1962 to 19&8.J Clin Oncol 1991; 9:1599-1608.
6. Brodeur GM, Seeger RC, Barret A, Berthold F, Castleberry RP, D'Angio G, De Bernard! B, Evans AE, Favrot M, Freeman AI, Haase G, Hartmann O, Hayes FA, Helson L, Kemshead J, Lamport F, Ninane J, Ohkawa H, Philip T, Pinkerton CR, Pritchard J, Sawada T, Siegel S, Smith El, Tsuchida Y, Voûte PA. International Criteria for Diagnosis, Staging, and Response to Treatment in patients with Neuroblastoma. J Clin Oncol 1988; 6:1874-1881.
7. Shimada H, Chatten J, Newton WA Jr et al. Histopathologic prognostic factors in neuroblastoma and an age-linked classification of neuroblaslomas. J Natl Cancer Inst1984; 73:405-416.
8. Brodeur GM, Seeger RC, Schawab M, Varmus HE, Bishop JP. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stages. Science 1984; 224:1121-4.
9. Gansler T, Chatten J, Varello M, Bunin GR, Atkinson B. Row Cytometric DNA Analysis of Neuroblastoma. Correlation with Histology and Clinical Outcome. Cancer 1986; 58:2453- 2458.
10. Chan ESL, Haddad G, Thorner PS, DeBoer G, Ping Lin Y, Ondrusek N, Yeger H, Ling V. P-Glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engt J Med 1991; 325:1608-1614.
11. Tanaka T, Hiyama E, Sugimoto T, Sawada T, Tanabe M, Ida N. trk A Gene Expression in Neuroblastoma. The Clinical significance of an Immunohistochemical Study. Cancer 1995; 76:1086-1095.
12. Castel V, Badal MD, Bezanilla JL, Herrero A, Llombart A, Rufz JI, Sânchez de Toledo J. Neuroblastoma. Resultados del Protocolo N-I87. An Esp Pediatr 1993; 38:471-476.
13. Castel V, Garcia-Miguel P, Melero C, Navajas A, Navarro S, Molina J, Badal MD, Rufz-Jiménez JI. The treatment of advanced neuroblastoma. Results of the Spanish Neuroblastoma Study Group (SNSG) Studies. Eur J Cancer 1995; 31A:642-645.
14. Castel V, Sânchez de Toledo J, Bezanilla JL, Badal MD. Neuroblastoma avanzado. Tratamiento de inducciôn (protocole multicéntrico N1-87). Oncologia 1990; 14:398- 405.
15. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, De Bernard! B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee RFJ, Look T, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voûte PA. Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging, and Response to Treatment. J Clin Oncol 1993; 11:1466-1477.
16. Kaplan EL, Meier P. Nonparametric estimation from imcomplete observations. J Am Statis Assoc 1958; 53:457-481.
17. Mantel N. Evaluation of survival data and two new ranck order statistics arising in its consideration. Cancer ChemotherRep 1966; 50:163170.
18. - Young JLJ, Miller RW. Incidence of malignant tumors in U.S. children. J Pediatr 1975; 86:254-258.
19. -Castel V, Canete A, Garcfa-Miguel P, Melero C, Navajas A, Badfa RM. Change in age and stage distribution of neuroblastoma patients in Spain. Localized Neuroblastoma Diagnosis-Treatment-Biology and 4th International Symposium on Neuroblastoma Screening Stuttgart 1995; Libro de abstractos pag 25.
20. Esteve J, Parker L, Hermann F, Duffy S, Frappaz D, Lasser C, Hill C, Sancho-Gamier H, Michaelis J, Philip T. Is neuroblastoma screening evaluation needed and feasible?. BrJ Cancer 1995; 71:1129-1131.
21. Takeuchi LA, Hachitanda Y, Woods WG, Tuchman M, Lemieux B, Brisson L, Berstein M, Brassard J, Ledere JM, Byrne TD, Triche TJ. Screening for Neuroblastoma in North America. Preliminary Results of a Pathology Review from the Quebec Project. Cancer 1995; 76:2363-2371.
22. Stiller CA, Parkin DM. International Variations in the incidence of neuroblastoma. IntJ Cancer 1992; 52:538- 543.
23. Stiller CA. Trends in neuroblastoma in Great Britain: incidence and mortality. 1971-1990. Eur J Cancer 1993;29A:1008-1012.
24. Draper GJ, Kroll ME, Stiller CA. Childhood cancer. Cancer Sun-1994; 19-20:493-517.
25. Blair V, Birch JM: Patterns and temporal trends in the incidence of malisnant disease in children: II. Solid tumours of childhood. EurJ Cancer 1994; 30A:1498-1511.
26. Ho FT, Estroff JA, Kozakewich H, Shamberger RC, Lillehei CW, Grier HE. Prenatal detection of neuroblastoma: a ten- year experience from the Dana-Farber Cancer Institute and Children's Hospital. Pediatrics 1993; 92:358-364.
27. Jennings RW, LaQuaglia MP, Leong K, Hendren WH, Adzick NS. Fetal neuroblastoma: prenatal diagnosis and natural history. J Pedialr Surg 1993; 28:1168-1174.
28. Hosoda Y, Miyano T, Kimura K, Oya T, Ishimoto K, Tamo M, Takeuchi H. Characteristics and management of patients with fetal neuroblastoma. J Pediatr Surg 1992; 27:623- 625.
29. Saylors RL 3rd, Cohn SL, Morgan ER, Brodeur GM. Prenatal detection of neuroblastoma by fetal ultrasonography. Am J Pediatr HematolOncol 1994; 16:356-360.
30. Martfnez-Mora J, Castellvi A, Coroleu W, Isnard R, Javier G, Lopez P, Monserrat E, Natal A, Ojanguren I, Orazabal A. Cystic adrenal neuroblastoma: prenatal diagnosis by ultrasonography. Med Pediatr Oncol 1995; 24:109-115.
31. Richards ML, Gundersen AE, Williams MS. Cystic neuroblastoma in infancy. J Pediatr Surg 1995; 30:1354-1357.
32. Murakami T, Ohmori H, Katoh T, Nakamura H, Tsuda T, Shan RC, Akiya A. Differences of L-myc polymorphic patterns of neuroblastoma in patients under 1 year versus older ages: a preliminary report. J Pediatr Surg 1992; 27:1442-1446.
33. Kemshead JT, Patel K, Phimister B. Neuroblastoma in the very young child: biological considerations. BrJ Cancer 1992; Suppl 18:102-105.
34. Grosfeld JL, Rescolda FJ, West KW, Goldman J. Neuroblastoma in the first year of life: clinical and biologic factors. Semin Pediatr Surg 1993; 2:37-46.
35. Berthold F, Engelhardt-Fahmer U, Schneider A, Schumacher R, Zieschang J. Age dependence and prognostic impact of Neuron Specific Enolase (NSE) in children with neuroblastoma. In vivo 1991; 5:245248.
36. Hann HL, Evans AE, Siegel SE y cols. Prognostic importante of serum ferritin in patients with stages III an IV neuroblastoma. The Childrens Cancer Study Group experience. Cancer Res 1985; -45:2843-2848.
37. Berthold F, Harms D, Lampert F et al. Risk factors in neuroblastoma of infants. Contrib Oncol 1990; 41:101-117.
38. Berthold F, Kassenbhmer R, Zieschang J. Multivariate evaluation of prognostic factors in localized neuroblastoma. Am J Pediatr HemalolOncol 1994; 16:107-115.
39. Evans AE, D'Angio GJ, Propert K et al. Prognostic factors in neuroblastoma. Cancer 1987; 59:1853-1859.
40. Sansone R, Strigini P, Badiali M, Dominici C, Fontana V, lolascon A, De Bernard! B, Tonini GP. Age-Dependent prognostic significance of N-myc Amplification in neuroblastoma. Cancer Genet Cytogenet 1991; 54:253-257.
41. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the trK gene and favourable outcome in human neuroblastoma. N EnglJMed 1993; 328:847-854.
42. Kushner BH, Cheung Nai-Kong VC, LaQuaglia MP, Ambros PF, Ambros IM, Bonilla MA, Gerald WL, Ladanyi M, Gildert F, Rosenfield NS, Yeh SDJ. Survival from Locally Invasive or Widespread Neuroblastoma without Cytotoxic Therapy./C/m Oncol 1996; 14:373-381.
43. Kushner BH, Cheung NV, LaQuaglia MP, Ambros PF, Ambros IM, Bonilla MA, Ladanyi M, Gerald WL. International Neuroblastoma System Stage 1 Neuroblastoma: A Prospective Study and Literature Review. J ClinOncol 1996; 14:2174-2180.
44. Michon J, De Bernardi B, Ambros P, Rubie H, Landenstein R, Castel V, De Rycke Y, Foot A, Nanadov-Beck M, Mosseri V, Roald B, Ambros I, De Kraker J, Delattre 0, Tonini GP, Gross N, Lunée J. Surgery only for 1NSS stage 2 neuroblastoma: Progress report from the Localized Neuroblastoma European Study Group (LNESG). Medand PedOncol 1996; 27:220.
45. Hasse GM, Atkinson JB, Stram DO et al. Surgical management and outcome of locoregional neuroblastoma. Comparison of the Childrens Cancer Group and the International staging systems. / Pediatr Surg 1995; 30:289-295.
46. Hasse GM, Wong KY, deLorimier AA et al. Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 1989; 24:194-200.
47. Tsuchida Y, Yokoyama J, Kaneko et al. Therapeutic significance of surgery in advanced neuroblastoma: A report from the Study Group of Japan. J Pediatr Surg 1992; 27:616- 622.
48. Ninane J, Pritchard J, Morris Jones PH et al. Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement. Arch Dis Child 1982; 57:438-442.
49. Rosen EM, Cassady JR, Kretschmar C et al. Influence of local-regional lymph node métastases on prognosis in neuroblastoma. Med Pediatr Oncol 1984; 12:260-263.
50. Castleberry RP, Shuster JJ, Altshuler G, Smith El, Nitschke R, Winick N, Me Williams N, Joshi V, Hayes FA. Infants with neuroblastoma and regional lymph node métastases have a favourable outlook after limited postoperative chemotherapy: a Pédiatrie Oncology Group Study. J Clin Oncol 1992,10:1299-1304.
51. Castel V, Badal MD, Bezanilla JL et al. Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: A report from the Neuroblastoma Group of the Spanish Society of Pédiatrie Oncology. Med Pediatr Oncol 1995; 24:29-35.
52. DeCou JM, Bowman LC, Rao BN, Santana VM, Furman WL, Luo X, Lobe TE, Kumar M. Infants with metastatic neuroblastoma have improved survival with resection of the primary tumor. J Pediatr Surg 1995; 30:937-941.
53. Paul SR, Tarbell NJ, Korf B, Kretschmar CS, Lavally B. Stage IV neuroblastoma in infants. Cancer 1991; 67:1493-1497.
54. Martinez DA, King DR, Ginn-Pease ME, Haase GM, Wiener ES. Resection of the primary tumor is appropiate for children with stage IV-S neuroblastoma: an analysis of 37 patients. J Pediatr Surg 1992; 27:1016-1020.
55. Guglielmi M, De Bemardi B, Rizzo A, Federici S, Boglino C, Siracusa F, Leggio A, Cozzi F, Cecchetto G, Musi L, Bardini T, Fagnani AM, Bartoli GC, Pampaloni A, Rogers D, Conte M, Milanaccio C, Bruzzi P. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: Does it affect the clinical course?./ Clin Oncol 1996; 14:1537-1544.
56. Taylor CP, McGuckin AC, Bown NP, Reid MM, Malcom AJ, Pearson AD. Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumor imprints and bone marrow smears. United Kingdom Children's Cancer Study Group, fir J Cancer 1994; 69:445-451.
57. Hedborg F, Lindgren PG, Johansson I, Kogner P, Samuelsson BO, Bekassy AN, Olsen L, Kreuger A, Pohlman S. N-myc gene amplification in neuroblastoma: a clinical approach using ultrasound guided cutting needle biopsies collected at diagnosis. Med Pediatr Oncol 1992; 20:292-300.